Status:
COMPLETED
The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Hemodialysis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.
Detailed Description
This study prospectively evaluate the impacts of low dose aspirin on survival and cardio-cerebral vascular events in a large cohort of Chinese patients undergoing chronic hemodialysis. Between January...
Eligibility Criteria
Inclusion
- All patients aged 18 to 85, undergoing chronic hemodialysis, who have none of the following exclusion criteria.
Exclusion
- History of gastric or duodenal ulcers Known allergy to aspirin or other NSAIDs
- \-
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT02261025
Start Date
January 1 2008
End Date
September 1 2014
Last Update
October 23 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.